Vitamin D and schizophrenia: what the evidence shows

Vitamin D is one of the most consistently abnormal lab values in people with schizophrenia. Multiple meta-analyses — including a frequently cited one by Valipour et al. in The Journal of Clinical Endocrinology and Metabolism (2014) — have found that people with schizophrenia have lower 25-hydroxyvitamin D levels than the general population, with deficiency rates of roughly 65 percent compared with 30 to 40 percent in age-matched controls. The association is real. What it means, and what to do about it, is more complicated.

Why levels are low

Several factors converge:

• Less time outdoors. Negative symptoms, sedation, and social withdrawal all reduce sun exposure, which is the body's main source of vitamin D production.
• Diet. Few foods are naturally rich in vitamin D; dietary intake in many populations is insufficient regardless of mental illness.
• Higher BMI. Vitamin D is fat-soluble; in people with obesity (more common in this population), more is sequestered in adipose tissue and less circulates.
• Skin pigmentation. Darker skin synthesises less vitamin D per minute of sun exposure, and rates of schizophrenia are somewhat higher in some immigrant populations living in northern latitudes.
• Latitude and season. Northern winters produce essentially no skin synthesis; this affects everyone but matters more for already-vulnerable populations.

The causal question

Three possible relationships could produce the observed association:

1. Low vitamin D contributes to schizophrenia risk or severity
2. Schizophrenia (through behaviour, weight, indoor living) lowers vitamin D
3. Both — a feedback loop

For risk, there is some evidence (notably from McGrath and colleagues' work on neonatal vitamin D and later schizophrenia risk in Danish cohorts) that low maternal or early-life vitamin D may modestly increase later schizophrenia risk. This would fit a developmental hypothesis but does not imply that adult supplementation reverses the disorder.

For treatment of established schizophrenia, randomised trials of vitamin D supplementation have been disappointing. The DFEND trial (Krivoy et al., 2017) and similar studies have generally not found meaningful improvements in psychotic symptoms from supplementation, even in deficient patients. Smaller positive findings have not consistently replicated.

What this means in practice

The honest summary is:

• If you have schizophrenia, your vitamin D level is more likely than average to be low
• Correcting deficiency is good for bones, muscle, and general health, regardless of effect on psychosis
• Supplementation is unlikely to change positive or negative symptoms meaningfully
• It is an inexpensive, low-risk addition to a treatment plan, not a substitute for one

How to get tested

The standard test is serum 25-hydroxyvitamin D (25(OH)D), sometimes written as 25-OH-D. It is widely available, inexpensive, and a single morning blood draw. Most labs report in either nmol/L (international convention) or ng/mL (US convention). To convert: ng/mL × 2.5 = nmol/L.

Common interpretive thresholds (Endocrine Society, 2011, with later refinements):

• Deficient: below 50 nmol/L (20 ng/mL)
• Insufficient: 50 to 75 nmol/L (20 to 30 ng/mL)
• Sufficient: 75 to 125 nmol/L (30 to 50 ng/mL)
• Toxicity risk: above 250 nmol/L (100 ng/mL)

How much to supplement

Dosing should be discussed with your prescriber, but typical evidence-based ranges (based on UK NICE guidance, US Endocrine Society, and Institute of Medicine recommendations) are:

• Most healthy adults: 600 to 800 IU daily for maintenance
• Mild deficiency: 1,000 to 2,000 IU daily, with retest in 8 to 12 weeks
• Severe deficiency: higher initial loading dose (e.g., 50,000 IU weekly for 6 to 8 weeks) followed by maintenance — this should be prescribed and monitored, not self-directed

Vitamin D3 (cholecalciferol) is generally preferred over D2 (ergocalciferol) for raising blood levels. The supplement should be taken with food containing some fat for absorption.

Sun exposure

For most people, 10 to 30 minutes of midday sun on the face and arms several times a week, in summer, produces meaningful vitamin D. This is not enough in winter at higher latitudes. Sunscreen blocks vitamin D synthesis but is still recommended for skin cancer prevention; supplementation is the better trade-off than skipping sunscreen.

Food sources

Few foods naturally contain meaningful vitamin D:

• Oily fish (salmon, mackerel, sardines, trout)
• Egg yolks (modest amount)
• Mushrooms exposed to UV light
• Fortified milks, cereals, and orange juice (variable; check the label)

Diet alone rarely brings a deficient person up to sufficient levels; supplementation usually does the work.

What about other vitamins and minerals?

Folate, B12, and zinc deficiencies have been reported at higher rates in schizophrenia, particularly in people with poor dietary intake or substance use. The case for supplementation is strongest when there is documented deficiency. General multivitamins are reasonable insurance for someone whose diet is restricted, but they are not a treatment for the disorder. Anything taken regularly should be on the medication list your prescriber sees.

The bigger picture

The vitamin D story is a useful template for how to think about lifestyle interventions in schizophrenia: the deficiencies are real, correcting them is reasonable, and the benefit is on general health and quality of life — not on psychotic symptoms themselves. The disorder is not caused by a vitamin deficiency, and no supplement will substitute for the core treatments. That said, fixing what can be fixed cheaply and safely is good medicine.

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.